| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
IVA
Inventiva
|
Sep 29, 2026 | BUY |
Strong Buy
+345.6% avg upside
17 analysts
|
— | · | · |
|
SRRK
Scholar Rock Holding
|
Sep 24, 2026 | BUY |
Strong Buy
+35.9% avg upside
23 analysts
|
$77.00
59.37% Upside
|
+0.0% | · |
|
EWTX
Edgewise Therapeutics
|
Sep 23, 2026 | BUY |
Strong Buy
+11.5% avg upside
15 analysts
|
— | -0.9% | · |
|
AXSM
Axsome Therapeutics
|
Sep 23, 2026 | BUY |
Strong Buy
+28.0% avg upside
30 analysts
|
$285.00
54.48% Upside
|
-4.2% | · |
|
NAMS
NewAmsterdam Pharma Company
|
Sep 22, 2026 | BUY |
Strong Buy
+96.5% avg upside
19 analysts
|
$57.00
134.30% Upside
|
+4.3% | · |
|
ABCL
AbCellera Biologics
|
Sep 02, 2026 | BUY |
Strong Buy
+10.6% avg upside
17 analysts
|
$30.00
105.65% Upside
|
+31.1% | · |
|
PTGX
Protagonist Therapeutics
|
Sep 01, 2026 | BUY |
Strong Buy
-14.8% avg upside
19 analysts
|
— | -4.0% | · |
|
CYTK
Cytokinetics
|
Sep 01, 2026 | BUY |
Strong Buy
+37.6% avg upside
36 analysts
|
$112.00
69.96% Upside
|
-8.1% | · |
|
OABI
OmniAb
|
Aug 18, 2026 | BUY |
Strong Buy
+63.5% avg upside
10 analysts
|
— | +20.9% | · |
|
CORT
Corcept Therapeutics
|
Aug 18, 2026 | BUY |
Buy
-42.1% avg upside
16 analysts
|
$164.00
42.33% Upside
|
-1.7% | · |
|
SEPN
Septerna, Inc.
|
Aug 13, 2026 | BUY |
Strong Buy
+32.4% avg upside
12 analysts
|
$59.00
50.72% Upside
|
-12.0% | · |
|
LLY
Eli Lilly & Co
|
Aug 11, 2026 | BUY |
Strong Buy
-6.8% avg upside
49 analysts
|
$1376.00
19.01% Upside
|
-4.6% | · |
|
MBX
MBX Biosciences, Inc.
|
Aug 10, 2026 | BUY |
Strong Buy
+34.5% avg upside
14 analysts
|
$88.00
50.10% Upside
|
-13.3% | · |
|
ARVN
Arvinas Holding Company
|
Aug 10, 2026 | HOLD |
Strong Buy
+272.0% avg upside
28 analysts
|
$8.68
12.29% Upside
|
-17.3% | · |
|
MDGL
Madrigal Pharmaceuticals
|
Jul 31, 2026 | BUY |
Strong Buy
+2.1% avg upside
34 analysts
|
$709.00
40.74% Upside
|
+6.9% | · |
|
BMY
Bristol-Myers Squibb
|
Jul 31, 2026 | BUY |
Buy
-1.3% avg upside
42 analysts
|
$70.00
12.19% Upside
|
-3.8% | · |
|
INCY
Incyte
|
Jul 29, 2026 | HOLD |
Buy
-9.0% avg upside
48 analysts
|
— | -7.8% | · |
|
ALT
Altimmune
|
Jul 29, 2026 | BUY |
Strong Buy
+836.7% avg upside
20 analysts
|
— | +4.8% | · |
|
FR:IVA
Inventiva
|
Jul 27, 2026 | BUY |
Strong Buy
+481.9% avg upside
6 analysts
|
— | -27.6% | · |
|
ABSI
AbSci
|
Jul 02, 2026 | BUY |
Strong Buy
+15.9% avg upside
19 analysts
|
$17.00
57.77% Upside
|
-18.3% | · |
|
KYMR
Kymera Therapeutics
|
Jun 29, 2026 | BUY |
Strong Buy
-1.2% avg upside
37 analysts
|
$136.00
21.59% Upside
|
+1.4% | · |
|
AVAH
Aveanna Healthcare Holdings
|
Jun 08, 2026 | HOLD |
Buy
-8.5% avg upside
19 analysts
|
— | +86.9% | · |
|
KROS
Keros Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+110.0% avg upside
21 analysts
|
— | +7.2% | · |
|
CRIS
Curis
|
Mar 23, 2026 | BUY |
Strong Buy
+1462.6% avg upside
12 analysts
|
— | · | · |
|
AMGN
Amgen
|
Nov 05, 2025 | HOLD |
Buy
-23.0% avg upside
57 analysts
|
— | +35.1% | · |
|
INSM
Insmed
|
Nov 03, 2025 | BUY |
Strong Buy
+51.6% avg upside
37 analysts
|
$214.00
87.41% Upside
|
-36.9% | · |
|
NRIX
Nurix Therapeutics
|
Oct 30, 2025 | BUY |
Strong Buy
+35.6% avg upside
28 analysts
|
$23.00
3.01% Downside
|
+85.2% | · |
|
REGN
Regeneron
|
Oct 29, 2025 | BUY |
Strong Buy
+5.5% avg upside
59 analysts
|
$812.00
7.02% Upside
|
+21.3% | · |
|
CVS
CVS Health
|
Oct 10, 2025 | BUY |
Strong Buy
+25.5% avg upside
39 analysts
|
$84.00
2.04% Downside
|
+13.5% | · |
|
CHRS
Coherus Biosciences
|
Aug 04, 2025 | HOLD |
Buy
+931.2% avg upside
18 analysts
|
— | +70.5% | · |
|
BIIB
Biogen
|
Jul 21, 2025 | HOLD |
Strong Buy
+13.2% avg upside
53 analysts
|
$142.00
37.17% Downside
|
+65.6% | · |
|
BMEA
Biomea Fusion
|
Jul 09, 2025 | HOLD |
Strong Buy
+904.9% avg upside
15 analysts
|
— | -32.8% | · |
|
MRK
Merck & Company
|
Feb 24, 2025 | HOLD |
Strong Buy
-1.9% avg upside
43 analysts
|
— | +40.9% | · |
|
ABBV
AbbVie
|
Feb 24, 2025 | HOLD |
Strong Buy
-6.9% avg upside
47 analysts
|
— | +15.7% | · |
|
PFE
Pfizer
|
Feb 24, 2025 | HOLD |
Buy
+17.8% avg upside
45 analysts
|
— | +9.2% | · |
|
AFMDQ
Affimed
|
Jan 28, 2025 | HOLD |
Buy
+14226263.7% avg upside
16 analysts
|
— | · | · |
|
NCNA
Nucana
|
Dec 23, 2024 | HOLD |
Buy
+895.3% avg upside
9 analysts
|
— | · | · |
|
RDNT
Radnet
|
Nov 12, 2024 | BUY |
Strong Buy
+19.4% avg upside
11 analysts
|
— | -10.9% | · |
|
VSTM
Verastem
|
Oct 18, 2024 | BUY |
Strong Buy
+93.6% avg upside
24 analysts
|
$15.00
86.25% Upside
|
+211.5% | · |
|
NMTRQ
9 Meters Biopharma
|
Mar 20, 2023 | HOLD |
Buy
+3234374900.0% avg upside
11 analysts
|
$38.00
3799999899.92% Upside
|
· | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.